JetBlue load factor falls, as capacity increases while traffic declines

JetBlue Airways Corp. said Tuesday that January load factor declined to 81.9% from 83.3% a year ago, as a capacity rose slightly while traffic declined. Capacity increased 0.1% to 4.64 billion available seat miles, while traffic fell 1.7% to 3.80 billion revenue passenger miles. The number of revenue passengers fell 4.0% to 3.16 million, while departures declined 2.5% to 28,596. The stock, which was still inactive in premarket trade, has rallied 4.9% over the past three months, while the NYSE Arca Airline Index has surged 9.7% and the S&P 500 has gained 2.8%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Barnes & Noble to book $11 million charge in Q3 after eliminating store positions

Barnes & Noble Inc. said Tuesday it expects to book a charge of about $11 million in fiscal third quarter after implementing a new staffing model that has led to the elimination of store positions. The company made the disclosure in a regulatory filing without specifying how many positions were cut. The bookstore chain said it expects the job cuts to save about $40 million a year. “The new model will allow stores to adjust staff up or down based on the needs of the business, increase store productivity and streamline store operations,” the company said in a statement. Shares rose 1.1% premarket, but have fallen 56% in the last 12 months, while the S&P 500 has gained 14%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Broadcom says it will seek to elect six, not 11, nominees to Qualcomm’s board

Broadcom Ltd. said Tuesday that it would seek to elect six members to Qualcomm Inc.’s board, rather than the 11 members it had originally planned. Broadcom has made an $82/share hostile bid for Qualcomm. If Broadcom’s slate were to be elected, the company said it would have a majority on the Qualcomm board. Qualcomm investors “have welcomed our willingness to provide for appropriate continuity on the Qualcomm board, and have also expressed a desire for a definitive mechanism of achieving such continuity,” Broadcom CEO Hock Tan said in a release. “Reducing the number of nominees we are seeking to a simple majority provides precisely that mechanism.” Qualcomm’s annual meeting is scheduled for March 6. Broadcom shares are up 18% over the past 12 months, while Qualcomm shares are up 20%. The S&P 500 Index has gained 14% in that time, while the Philadelphia Semiconductor Index is up 32%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Walgreens takeover of Amerisource would boost earnings, but rationale puzzling: Jefferies

A takeover of drug distributor AmerisourceBergen Corp. by Walgreens Boots Alliance Inc. would boost Walgreen’s per-share earnings, but would be a headscratcher for investors, Jefferies analysts wrote Tuesday. Walgreens recently approached Amerisource CEO Steven Collis with a view to buying the stake in the company it does not already own, as The Wall Street Journal reported late Monday. Walgreens owns a 26% stake in the company. “While we see strategic value in joining forces with a leading drug distributor such as ABC, we believe WBA has already pursued this opportunity when it formed the WBAD purchasing consortium with ABC and acquired its minority stake in the company,” Jefferies analysts wrote in a note. “WBA has been openly discussing their intention of continuing to pursue vertical-integration deal opportunities, but acquiring the rest of ABC, while financially-rational, begs the question on what incremental strategic value the deal would bring, especially in light of recent moves by CVS and AET and even ESRX buying eviCore.” A deal would however help Walgreens expand in the U.S. and reduce its reliance on the UK’s Boots chain, at a time when the UK market is facing reimbursement and macro pressures, they wrote. Walgreens shares were down 1.7% premarket, while Amerisource was up 13%. S&P 500 futures were down 0.4%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Blue Apron shares surge after revenue beats expectations

Blue Apron Holdings Inc. shares jumped 7.5% in Tuesday premarket trading after it reported fourth-quarter losses that weren’t as deep as expected and revenue that beat expectations. The meal delivery service reported a loss of $39.1 million, or 20 cents per share, compared with a loss of $26.1 million, or 39 cents per share for the same period last year. Revenue fell 13% to $187.7 million, down from $215.9 million last year. The FactSet consensus was for a loss of 27 cents and revenue of $185.0 million. Marketing expenses fell to $25.2 million from $37.1 million as the company’s “top priority remains continuing to drive operational efficiencies,” Chief Executive Brad Dickerson said in a statement. Customers fell 15% year-over-year, also reflecting a cut in marketing spend. Blue Apron shares are up 9.5% for the last three months, but down nearly 17% for the year-to-date. The S&P 500 index is down 0.7% for the year so far.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Eli Lilly’s Taltz meets primary endpoint in late-state trial for AS treatment

Eli Lilly & Co. said Tuesday that a phase 3 safety and efficacy study of Taltz for the treatment of ankylosing spondylitis (AS) met the primary and all key secondary endpoints. Eli Lilly said it plans to submit data for regulatory approval, pending additional data from the ongoing Taltz development program. Taltz is currently approved for treatment of psoriatic arthritis in adults, and to treat adults with moderate-to-severs plaque psoriasis. Eli Lilly’s stock, which is still inactive in premarket trade, has shed 8.0% over the past three months, while the SPDR S&P Pharmaceuticals ETF has gained 1.1% and the S&P 500 has tacked on 2.8%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Blue Apron shares spike after revenue beats expectations

Blur Apron Holdings Inc. shares jumped 7.5% in Tuesday premarket trading after it reported fourth-quarter losses that weren’t as deep as expected and revenue that beat expectations. The meal delivery service reported a loss of $39.1 million, or 20 cents per share, compared with a loss of $26.1 million, or 39 cents per share for the same period last year. Revenue fell 13% to $187.7 million, down from $215.9 million last year. The FactSet consensus was for a loss of 27 cents and revenue of $185.0 million. Marketing expenses fell to $25.2 million from $37.1 million as the company’s “top priority remains continuing to drive operational efficiencies,” Chief Executive Brad Dickerson said in a statement. Customers fell 15% year-over-year, also reflecting a cut in marketing spend. Blue Apron shares are up 9.5% for the last three months, but down nearly 17% for the year-to-date. The S&P 500 index is down 0.7% for the year so far.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

GNC’s stock rockets after big investment from China’s Harbin Pharmaceutical

GNC Holdings Inc. shares soared 35% in premarket trade Tuesday, after the health and performance supplements retailer said it will receive a $300 million investment from China-based drugmaker Harbin Pharmaceutical Group Holding Co. (Hayao), as part of a strategic partnership and China joint venture agreement. The investment makes Hayao the largest GNC shareholder. GNC is also looking to extend the maturity date of its existing term loan facility by two years to March 2021. Separately, the company GNC reported a fourth-quarter net loss that narrowed to $209.8 million, or $2.99 a share, from $433.4 million, or $6.35 a share, in the same period a year ago. Excluding non-recurring items, the adjusted profit per share came to 25 cents, matching the FactSet consensus. Revenue fell to $557.7 million frmo $569.9 million, missing the FactSet consensus of $568.8 million. Same-store sales rose 5.7% in domestic company-owned stores, but decreased 2.0% in domestic franchise stores. The stock has plunged 30% over the past three months through Monday, while the S&P 500 rose 2.8%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

UPDATE: Under Armour shares surge 13% after revenue beat

Under Armour Inc. shares surged 13% in premarket trade Tuesday, after the company posted stronger-than-expected revenue for the fourth quarter. The company said it had a net loss of $87.9 million, or 20 cents a share, in the quarter, after earnings of $103.2 million, or 23 cents a share, in the year-earlier period. Adjusting for a one-time tax charge and restructuring costs, the company had breakeven EPS, matching the FactSet consensus. Revenue came to $1.4 billion, beating the FactSet consensus of $1.3 billion. The company said it recognized pretax costs relating to a restructuring plan announced last August of $37 million. The company is now expecting to book restructuring charges of $110 to $130 million in 2018 after identifying further measures. It expects to generate at least $75 million in annual savings from the restructuring in 2019 and beyond. For 2018, the company is expecting revenue to rise at a low single-digit percentage rate, and for adjusted EPS to range from 14 cents to 19 cents. The current FactSet consensus is for 2018 EPS of 21 cents. Shares have fallen 29% in the last 12 months, while the S&P 500 has gained 14%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Gunmaker Remington to file for bankruptcy

U.S. firearm manufacturer, Remington Outdoor Company, said it will file for Chapter 11 bankruptcy protection, but stay in business throughout the process. “Difficult industry conditions make today’s agreement prudent,” said Jim Geisler, Remington’s executive chairman, in a statement released by the company on Monday. The company has been dogged by falling sales after one of its rifles was used in the Sandy Hook Elementary School massacre of 2012. The restructuring will help the company to cut its debt by around $700 million and inject $145 million in new capital into its different units. Remington said its business operations will not be affected by the restructuring. Remington is owned by Cerberus Capital Management, but CNN reported that once the restructuring process is over, the private equity firm will no longer own the company. Remington could not immediately be reached to comment on its relationship with Cerebus in future.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News